McKesson EBIT 2010-2024 | MCK

McKesson EBIT for the quarter ending June 30, 2024 was $1.029B, a 6.45% decline year-over-year.

  • McKesson 2024 EBIT was 3.909B, a 10.77% decline from 2023.
  • McKesson 2023 EBIT was 4.381B, a 114.97% increase from 2022.
  • McKesson 2022 EBIT was 2.038B, a 140.44% decline from 2021.

EBIT can be defined as earnings before interest and taxes.

McKesson EBIT 2010-2024 | MCK

  • McKesson 2024 EBIT was 3.909B, a 10.77% decline from 2023.
  • McKesson 2023 EBIT was 4.381B, a 114.97% increase from 2022.
  • McKesson 2022 EBIT was 2.038B, a 140.44% decline from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Becton Dickinson (BDX)$66.8B
Cardinal Health (CAH)$26.9B
Cooper (COO)$21.9B
West Pharmaceutical Services (WST)$21.5B
Labcorp (LH)$19.1B
Align Technology (ALGN)$18.9B
Henry Schein (HSIC)$9B
Merit Medical Systems (MMSI)$5.7B
DENTSPLY SIRONA (XRAY)$5.4B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.9B
STAAR Surgical (STAA)$1.6B
Lifevantage (LFVN)$125M
Pro-Dex (PDEX)$83M